Cermin Dunia Kedokteran
Vol 46 No 6 (2019): Endokrinologi

Terapi Diabetes dengan SGLT-2 Inhibitor

Pande Made S. Dharma Pathni (Medical Department, PT Kalbe Farma Tbk., Jakarta, Indonesia)



Article Info

Publish Date
03 Jun 2019

Abstract

SGLT-2 adalah transporter glukosa yang terletak di tubulus proksimal ginjal dan bertanggung jawab terhadap 90% reabsorpsi glukosa. Inhibisi terhadap transporter ini akan berdampak pada penurunan kadar glukosa darah dengan cara meningkatkan ekskresi glukosa melalui ginjal, namun kerjanya tergantung kadar glukosa. SGLT-2 is a glucose transporter located at renal proximal tubules and responsible for 90% glucose reabsorption. Inhibition to this transporter resulted in a decrease of blood glucose through increased renal glucose excretion, but the action is dependent on blood glucose level.

Copyrights © 2019






Journal Info

Abbrev

cdk

Publisher

Subject

Health Professions

Description

Cermin Dunia Kedokteran (CDK) is a Medical Journal published since 1974 and affiliated with PT Kalbe Farma Tbk. CDK is intended to help accommodate scientific publications and help increase and disseminate knowledge related to the development of medical science, pharmacy, and public health. CDK ...